116 related articles for article (PubMed ID: 36214145)
21. Trends in net survival from prostate cancer in six European Latin countries: results from the SUDCAN population-based study.
Grosclaude P; Roche L; Fuentes-Raspall R; Larrañaga N;
Eur J Cancer Prev; 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study():S114-S120. PubMed ID: 28005614
[TBL] [Abstract][Full Text] [Related]
22. Prostate cancer incidence and mortality in the Baltic states, Belarus, the Russian Federation and Ukraine.
Patasius A; Innos K; Barchuk A; Ryzhov A; Leja M; Misins J; Yaumenenka A; Smailyte G
BMJ Open; 2019 Oct; 9(10):e031856. PubMed ID: 31601600
[TBL] [Abstract][Full Text] [Related]
23. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons.
Quinn M; Babb P
BJU Int; 2002 Jul; 90(2):162-73. PubMed ID: 12081758
[TBL] [Abstract][Full Text] [Related]
24. Incidence and Mortality of Prostate Cancer in Canada during 1992-2010.
Lagacé F; Ghazawi FM; Le M; Savin E; Zubarev A; Powell M; Moreau L; Sasseville D; Popa I; Litvinov IV
Curr Oncol; 2021 Feb; 28(1):978-990. PubMed ID: 33617514
[TBL] [Abstract][Full Text] [Related]
25. [The incidence, mortality and risk factors of prostate cancer].
Nesvadba M; Cmorej P; Mamova A; Slowik O
Epidemiol Mikrobiol Imunol; 2016; 65(4):211-214. PubMed ID: 28078896
[TBL] [Abstract][Full Text] [Related]
26. [Descriptive epidemiology of prostate cancer in Japan and Western countries].
Wakai K
Nihon Rinsho; 2005 Feb; 63(2):207-12. PubMed ID: 15714967
[TBL] [Abstract][Full Text] [Related]
27. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
28. [Epidemiological trends in prostate cancer over the last years].
Luján Galán M; Páez Borda A; Chiva Robles V; Santonja Garriga C; Romero Cajigal I; Berenguer Sánchez A
Arch Esp Urol; 2004 Oct; 57(8):817-25. PubMed ID: 15560270
[TBL] [Abstract][Full Text] [Related]
29. Trends in cancer mortality in 15 industrialized countries, 1969-1986.
Hoel DG; Davis DL; Miller AB; Sondik EJ; Swerdlow AJ
J Natl Cancer Inst; 1992 Mar; 84(5):313-20. PubMed ID: 1738181
[TBL] [Abstract][Full Text] [Related]
30. Differences in the epidemic rise and decrease of prostate cancer among geographical areas in Southern Europe. an analysis of differential trends in incidence and mortality in France, Italy and Spain.
Quaglia A; Parodi S; Grosclaude P; Martinez-Garcia C; Coebergh JW; Vercelli M
Eur J Cancer; 2003 Mar; 39(5):654-65. PubMed ID: 12628846
[TBL] [Abstract][Full Text] [Related]
31. Time trend and age-period-cohort effect on kidney cancer mortality in Europe, 1981-2000.
Pérez-Farinós N; López-Abente G; Pastor-Barriuso R
BMC Public Health; 2006 May; 6():119. PubMed ID: 16672041
[TBL] [Abstract][Full Text] [Related]
32. International variations in bladder cancer incidence and mortality.
Chavan S; Bray F; Lortet-Tieulent J; Goodman M; Jemal A
Eur Urol; 2014 Jul; 66(1):59-73. PubMed ID: 24451595
[TBL] [Abstract][Full Text] [Related]
33. International variation in prostate cancer incidence and mortality rates.
Center MM; Jemal A; Lortet-Tieulent J; Ward E; Ferlay J; Brawley O; Bray F
Eur Urol; 2012 Jun; 61(6):1079-92. PubMed ID: 22424666
[TBL] [Abstract][Full Text] [Related]
34. The incidence rate of prostate cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from the Saudi Cancer Registry 2001-2008.
Alghamidi IG; Hussain II; Alghamdi MS; El-Sheemy MA
Hematol Oncol Stem Cell Ther; 2014 Mar; 7(1):18-26. PubMed ID: 24239850
[TBL] [Abstract][Full Text] [Related]
35. Prostate cancer incidence in Podkarpackie province in 2002-2011.
Karczmarek-Borowska B; Radziszewska A
Przegl Epidemiol; 2015; 69(1):65-72, 163-7. PubMed ID: 25862450
[TBL] [Abstract][Full Text] [Related]
36. A comparative population-based study of prostate cancer incidence and mortality rates in Singapore, Sweden and Geneva, Switzerland from 1973 to 2006.
Chen C; Naidoo N; Yang Q; Hartman M; Verkooijen HM; Loy EY; Bouchardy C; Chia KS; Chia SE
BMC Cancer; 2012 Jun; 12():222. PubMed ID: 22673095
[TBL] [Abstract][Full Text] [Related]
37. Survival in men diagnosed with prostate cancer in Poland in the years 2000 - 2014 compared to European Countries based on Concord-3.
Gliniewicz A; Dudek-Godeau D; Bielska-Lasota M
Rocz Panstw Zakl Hig; 2020; 71(4):445-453. PubMed ID: 33355426
[TBL] [Abstract][Full Text] [Related]
38. Trends of liver cirrhosis mortality in Europe, 1970-1989: age-period-cohort analysis and changing alcohol consumption.
Corrao G; Ferrari P; Zambon A; Torchio P; Aricò S; Decarli A
Int J Epidemiol; 1997 Feb; 26(1):100-9. PubMed ID: 9126509
[TBL] [Abstract][Full Text] [Related]
39. Prostate cancer incidence trends in Spain before and during the prostate-specific antigen era: impact on mortality.
Larrañaga N; Galceran J; Ardanaz E; Franch P; Navarro C; Sánchez MJ; Pastor-Barriuso R;
Ann Oncol; 2010 May; 21 Suppl 3():iii83-89. PubMed ID: 20427365
[TBL] [Abstract][Full Text] [Related]
40. [Epidemiologic indicators of adenocarcinoma of the prostate. Results on 436 patients].
Arrizabalaga Moreno M; García González JI; Diez Rodríguez JM; Esteban Artiaga R; Castro Pita M; Navarro Sebastian J; Mora Durbán M; Paniagua Andrés P
Actas Urol Esp; 1997 Oct; 21(9):852-61. PubMed ID: 9471868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
